Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the captcha-bank domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home1/c306474/public_html/wp-includes/functions.php on line 6131
Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the email-users domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home1/c306474/public_html/wp-includes/functions.php on line 6131
Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home1/c306474/public_html/wp-includes/functions.php on line 6131 Hiv Archives - TalkAfrique Deprecated: Function WP_Dependencies->add_data() was called with an argument that is deprecated since version 6.9.0! IE conditional comments are ignored by all supported browsers. in /home1/c306474/public_html/wp-includes/functions.php on line 6131
Deprecated: Function WP_Dependencies->add_data() was called with an argument that is deprecated since version 6.9.0! IE conditional comments are ignored by all supported browsers. in /home1/c306474/public_html/wp-includes/functions.php on line 6131
The 'jaboya' system is thought to be a contributing factor to high levels of HIV in Nyanza Province, Picture by Joanne Chui (http://www.flickr.com/photos/jo_photography/5455766518/)
KISUMU, 19 December 2011 (PlusNews) – For the past five years, Achieng*, a 35-year-old widow and mother of six, has sold fish on the Kenyan shores of Lake Victoria; like many women in the fish trade, Achieng often has to have sex with fishermen in order to get the best catch of the day, a system known in the local Luo language as ‘jaboya’.
“When you are a woman and you want to get into the business of selling fish, you must be ready to lose your pride and use your body for bargaining,” she told IRIN/PlusNews. “Being ready to give sex as and when it is needed by the fishermen… it guarantees your survival here on the beach.”
‘Jaboya’ has long been associated with the high levels of HIV infection in Kenya’s western Nyanza Province, where HIV prevalence is over 14.9 percent, double the national average of 7.4 percent. It is even higher among fishing communities. The Kenya HIV Prevention Response and Modes of Transmission Analysis 2009 reported that HIV prevalence among fishing communities stands at 30 percent, while an estimated 25 percent of all new infections in Nyanza are attributed to this group.
An estimated 27,000 women are involved in the fish trade in Nyanza either directly or indirectly, according to the Ministry of Fisheries.
Achieng says she is aware of the risks, but the immediate needs of her family override any concern she may have about contracting HIV.
“You know you can get HIV… but then you remember you have a family that needs to be provided for, and you say, let me die providing for them,” she said
According to Charles Okal, the provincial AIDS and sexually transmitted infections coordinator for Nyanza, while efforts to reach out to fishing communities with HIV prevention messages have begun to show results, the continued poverty of women means they remain vulnerable to ‘jaboya’.
“Fish trade that goes along with sex-for-fish continues to be one of the greatest challenges in the prevention of HIV in Nyanza… There are still challenges which involve the economic and social vulnerabilities of the women involved in the trade,” he said.
Economic empowerment
A recent donation of six boats to women’s groups in Nyanza by the US Peace Corps shows some of the ways ‘jaboya’ can be addressed; the women are able to fish for themselves, eliminating dependence on fishermen.
“When you have nothing, those who have something must tell you to bend over backwards for them. Now we have boats and we will no longer be at anybody’s mercy,” Millicent Onyango, one of the beneficiaries of the US Peace Corps’ “No Sex for Fish” project.
According to Okeyo Owuor, director of the Victoria Institute for Research on Environment and Development, which is part of the initiative, empowering women economically is key to ending the dangerous fish-for-sex trade. “These women need fish but they don’t own any boat. This means they have to play along with whoever has the boat and these are men who will demand for sex before giving any fish. But when you empower them to own the boat, then they have the ultimate power to say no to sexual demands,” he said.
“Six boats might look small but many such initiatives can make an impact in ending the sex-for-fish trade if replicated over time. It is important to start from somewhere,” he added.
Many of the women trading in fish across Lake Victoria’s landing sites have formed groups to help them save money to buy their own fishing equipment.
“We want to help ourselves by putting some of our savings aside so that when we have enough, we can buy our own boats and nets and help each other. So we will have nearly all women who are at the beaches own a boat either individually, or as a group,” said Lillian Rajula, the leader of one such group.
According to Nyanza AIDS coordinator Okal, economic programmes must go hand in hand with other HIV prevention methods like the promotion of voluntary medical male circumcision, condom use and behaviour change communication.
“Apart from the need to empower the women, behaviour change communication targeting men is important so that they look at the women as business partners and not sex partners; these kind of efforts are ongoing and are being embraced, albeit slowly,” he said.
Depression is the most common psychiatric disorder among HIV-positive people, Photo: Eva-Lotta Jansson/IRIN
ADDIS ABABA, 7 December 2011 (PlusNews) – HIV patients in Africa frequently suffer shame and depression but the continent’s health systems are ill-equipped to handle the issue, which not only affects their quality of life, but can lead to poor adherence to HIV treatment regimens.
While HIV programmes focus heavily on reducing externalized stigma and ill-treatment of HIV patients by society, little is done to deal with a patients’ self-perception and how that might deteriorate following an HIV diagnosis, speakers said at a session on stigma at the 16th International Conference on AIDS and Sexually transmitted infections in Africa in Addis Ababa.
Studies show that depression is the most common psychiatric disorder among people living with HIV, and is more prevalent among HIV-positive people than the general population.
“Operational research carried out in Zambia has found a positive correlation between patients who self-stigmatized and failure to adhere to treatment,” said Sikazwe Izukanyi from Zambia’s Ministry of Health. “Self-stigma was often found in patients who did not disclose their status to partners or family members – making it difficult to maintain strict adherence to regimens while trying to hide the drugs.”
Izukanyi noted that while counselling was a standard part of HIV care in Zambia, counsellors needed to be made aware of the prevalence of self-stigma and how to deal with it.
A 2010 Ugandan study by Makerere University found that HIV-positive patients were more critical of themselves, had significantly greater problems making decisions, poorer sleep, tired more easily, experienced more appetite changes and had more cognitive impairment.
ARVs and self-stigma
According to a study by Yordanos Tiruneh, an Ethiopian academic with US-based Northwestern University, antiretroviral (ARV) therapy has been key to reducing external stigma by minimizing the visibility of physical imperfections and restoring functional daily activities such as the ability to work. The study, which used 105 interviews with Ethiopian men and women on ARVs, also found that the support networks formed by people living with HIV gave them much-needed social capital.
However, according to Yordanos, while ARVs were linked to a reduction in external stigma, the study found that they tended to increase internalized stigma, sometimes resulting in failure to properly adhere to ARVs.
“When I think of the two tablets that keep me alive, I hate myself and I feel that I am dead,” one of the study’s interviewees is quoted as saying. “Sometimes I get furious to see myself like a walking corpse, and other times I see myself as a doll that functions with a battery. I would say, without these batteries [pills], I am nothing.”
According to a US study, adherence to ARVs was higher in patients for whom anti-depressants were prescribed.
A severe shortage of mental health professionals in Africa means that HIV-associated depression is largely ignored. For instance, according to the UN World Health Organization, Burundi has just one psychosocial care provider per 100,000, against a target of at least eight, while Ethiopia has less than one, against a similar target.
“The problem is largely a human resources one; while strengthening health systems, governments should remember to focus on mental-health issues,” said Izukanyi. “As it is, we have no systems for screening, diagnosing and treating patients with mental-health issues.”
Among other things, experts recommend integrating mental-health services into primary healthcare activities, developing mechanisms to ensure a good supply of psychotropic medication and more research into mental-health issues in Africa.
Although 100% condom programmes can be effective in increasing condom use in commercial sex transactions, they should be implemented in ways that do not violate the human rights of sex workers or their clients.
This is one of the recommendations in a report on human rights and the Global Fund recently released by the Canadian HIV/AIDS Legal Network and the Open Society Foundations (OSF).
These 100% condom use programmes (also called 100% CUP) are a central part of national HIV responses in a number of countries, including China, Cambodia, Vietnam, Thailand, Mongolia, Laos and Myanmar.
These programmes, which are designed to ensure that condoms are used in all commercial sex transactions, usually target sex workers in brothels or entertainment establishments. According to the report, in most cases, the strategy is to make commercial sex without condoms illegal and to enforce that illegality – which means that local authorities and the police are, inevitably, integrally involved in these programmes.
The report acknowledged that evaluations have found these programmes to be effective in reducing unsafe sex in commercial sex establishments. However, the report added, although they are meant to protect sex workers and their clients, in most cases the programmes have been designed without meaningful participation of sex workers or their NGO allies. Also, sex workers’ experiences have not frequently figured in evaluations of these programmes.
Finally, according to the report, several studies have documented abusive practices in these programmes, such as: forced registration of sex workers; mandatory STI testing and health examinations at health facilities where sex workers were mistreated; repressive policing; force-marching of sex workers to health facilities with military or police escorts; and public posting of photographs of sex workers who are accused of having had sex without condoms.
In one of these studies, the report said, sex workers reported that they were forced by brothel and nightclub owners to have sex with police in exchange for the police looking the other way when 100% CUP rules were violated.
The authors argued that there are other ways to achieve the target of 100% condom use, without having to resort to mandatory and abusive measures. The report cited the example of sex worker collectives such as those in the Sonagachi neighbourhood of Kolkata, India. The authors said that these collectives have created an environment that ensures that all workers demand condom use; and that the work of these collectives has resulted in both (a) effective HIV prevention and (b) empowering sex workers to stand up to police brutality and stigma in the community.
However, the report said, it may be that these alternative strategies are not well known to CCMs. The use of 100% CUP continues to be supported by CCMs; for example, in a Round 9 Indonesia proposal, the programme included promulgating and enforcing local regulations so that regular condom use would become the norm where sex is sold.
The Legal Network and the OSF recommended that the Global Fund develop criteria that would allow it to identify and reject proposals that include prevention programmes for sex workers that exhibit a lack of human rights protections for the workers and their clients. The report said that CCMs or other applicants that propose 100 percent condom programmes should be required to provide detailed information about the implementation of these programmes, including, for example:
the nature and degree of participation of organisations that are legitimate representatives of sex workers in the design, implementation and evaluation of these programmes;
measures taken to protect sex workers against abuse by clients, police and managers of brothels or entertainment venues; and
measures taken to consider less top-down alternatives to 100% CUP.
Finally, the authors recommended that the Technical Review Panel (TRP) be fully briefed on 100% CUP and alternatives to it; and that the Global Fund invest in capacity-building for CCMs in this area, including providing them with information on best practices
Mr Bill Gates: co-chair of the Bill & Melinda Gates Foundation
Mr. President, Prime Minister Sheikh Hasina, Director-General Dr. Margaret Chan, Excellencies, ladies and gentlemen.
The World Health Organization and this assembly have set the standard for global cooperation in pursuit of better health. For decades, you have established ambitious goals, such as eradicating smallpox. And you have rallied the world to accomplish those goals. It is an honor to join you today.
I had the privilege of addressing this assembly in 2005, when my wife Melinda and I were new to global health. At that time, we were so optimistic about the future. The world was finally starting to use its greatest resource, innovation, to solve this difficult problem – the fact that billions of people don’t have the chance to lead a healthy, productive life.
In the past six years, my optimism has continued to grow.
An recent important new book Getting Better by the economist Charles Kenny shows that life is getting better, rapidly, for people in poor countries. To build his argument, he examines a series of key quality-of-life indicators, including child survival, school enrollment, and levels of violence.
I hope this book gets the acclaim it deserves. It proves that the great work this assembly has been leading is having an enormous impact. We need the people who make funding decisions and set policy to understand the progress being achieved every day. I believe we have the opportunity to make even more progress, faster, for more people.
This opportunity is the reason I devoted my time to the Gates Foundation. Health and development is the most rewarding work I can think of, and Melinda and I will devote the rest of our lives to it.
When I was a teenager, I was captivated by computers because I believed they would change the world. I couldn’t predict exactly what the future would look like, but I was amazed by a sense to improve and empower.
Over the years, as I watched so much change taking root, I also saw glimpses of what was not changing. In 1994, I traveled to sub-Saharan Africa. It was impossible to ignore the devastating impact of disease and poverty on people’s lives.
Then, in 1998, Melinda and I read an article about rotavirus. We learned that it was the leading cause of diarrhea in young children – and that it caused 500 000 deaths annually. Our first child had just been born, and there was a good chance she’d suffered from rotavirus. But in the United States, children don’t die from diarrhea, so this was not a worry for us.
We’d never been forced to reckon with rotavirus, in fact, we’d never even heard of it because there was no chance our daughter would be killed by it.
This was a sobering realization for me. I had built my life around the idea that innovation is for everyone. When I began to understand how billions of people are deprived of its benefits, it made me angry. That’s when I decided to use my personal wealth would be used to help confront that inequity.
Thirty years ago, when I founded Microsoft my colleagues and I envisioned a computer for everyone. Now, I join you in seeking good health care for every human being.
At the Gates Foundation, our goal is to spur innovation on health problems.
Our priorities are your priorities: to make motherhood safer; to ensure that newborns survive their first 30 days; to provide children with a nutritious diet.
We see what you see everyday – that diseases like HIV, tuberculosis, and malaria can destroy communities. Along with great partners like the Global Fund, we want to help you diagnose, treat, and above all, prevent disease.
As we think about how to deploy our resources most effectively, one intervention stands out: vaccines.
Today, I would like to talk about how you can provide the leadership to make this the Decade of Vaccines.
Vaccines are an extremely elegant technology. They can be inexpensive, they are easy to deliver, and they are proven to protect children lifelong from disease. At Microsoft, we dreamed about technologies that were so powerful and yet so simple. Today, I like to imagine what the future will look like when world leaders start to take full advantage of vaccines.
In this Decade, we can achieve a lot.
Early in this decade, we will eradicate polio.
By the end of the decade, five or six new vaccines will be available to all children of the world.
And, crucially, every country in the world will have built a delivery system made to get vaccines to every last child.
To put an end to polio and reach all children with new vaccines, we must create strong immunization programmes.
In January of last year, I called for the world to accelerate progress on vaccines. That was a moment, and now there is momentum. I’m excited that global health leaders are now collaborating to put a specific global vaccine action plan in place.
The success of that plan will be a blueprint for the success of the Decade of Vaccines. It will depend on us to do our best work.
Vaccines and immunization
The greatest asset of every country is the energy and talent of its people. Disease saps that energy and squanders that talent. Repeated intestinal infections stunt children’s growth and reduce their cognitive development. Meningitis can cause permanent neurologic disability. Malaria prevents people from being productive; over a lifetime, high rates of malaria are cause substantially reduced earnings.
That’s why vaccines are one of the best investments we can make in the future: healthy people drive thriving economies. As we free billions of people from the relentless burden of sickness and death will unleash more human potential than ever before.
Let me give you an example of the difference vaccines can make.
This year, 20 million children will have severe pneumonia. More than a million will die. But even when the disease doesn’t take a child’s life, it can affect the child’s and family’s future.
For the survivors, the sickness reduces their chances of growing up healthy and strong. Their parents will go into debt. But we now have vaccines against two of the leading causes of pneumonia which make it possible for countries to reduce the burden and tap into people’s energy and nurture their talent.
Product development
The pneumonia vaccines are a symbol of one of the most exciting trends in global health, the drive towards equity in delivering innovations.
In the past, innovations developed vaccines for rich countries, and it took more than a decade before they were introduced in poor countries. But that is changing.
The newest pneumonia vaccines were available in developing countries only a few years after they were approved for use in developed countries. The same is true of a new rotavirus vaccine. But approved and available don’t mean delivered. Now it is up to the GAVI Alliance and many of you in this room to ensure that these vaccines reach the children who need them.
Last December, Burkina Faso, Mali, and Niger made history when they introduced a brand new vaccine for Meningitis A, the first vaccine developed specifically for use in Africa.
The story began in 1996, when the deadliest meningitis epidemic in memory tore through 25 countries in Africa, infecting more than 250 000 people. Meningitis strikes with frightening speed. A perfectly healthy child can be playing with friends one minute and literally be dead a few hours later.
In 1996, the only weapon against meningitis was barely useful at all, a short-lasting vaccine that wasn’t effective among young children. Health officials used it to control outbreaks that were already raging, so they called it “medicine after death.” They demanded a better vaccine that could prevent outbreaks.
The WHO and an organization called PATH formed the Meningitis Vaccine Project in 2001. The partners set a target price of 50 cents for the vaccine, which would make it affordable.
But producing a vaccine at that low price required a new approach to drug development. The Meningitis Vaccine Project worked with a Dutch biotech company to obtain key raw materials and arranged a technology transfer from the United States. Then, the Serum Institute of India agreed to manufacture the vaccine at the target price.
I am pleased to announce that we now have very early results from the use of vaccines from Burkina Faso. In the first 16 weeks of this year, there was just a single case of meningitis reported in the country.
It’s too soon to declare victory, but the early data makes me hopeful. For centuries, meningitis terrorized a region of 400 million people. This vaccine can help end the terror.
We need to continue creating and delivering more vaccines, but finally, for the first time, we can see a bright future.
Vaccine coverage
To keep the promise of equitable access to health care, all new vaccines must be priced low enough so that all countries can afford them. The Gates Foundation is working with many vaccine manufacturers to ensure that vaccines are available at a reasonable price. I believe that we can cut the combined price of the pentavalent, pneumococcus, and rotavirus vaccines in half by 2016.
But even when prices are fair, delivering vaccines to every child takes a great commitment.
Many developing countries are already doing a great job. Bangladesh, Nicaragua, Rwanda, and Vietnam routinely reach about 90 percent of their infants. But there are many places where vaccination rates are low. Almost every country can do better, must do better, if this decade is to reach the potential of the Decade of Vaccines.
Leading a health ministry is a hard job. You face a multitude of complicated choices. The stakes are always life and death and you have many priorities.
But you all have access to one key resource: your own leadership. And leadership can be decisive. The best immunization systems work because leaders hold themselves accountable for results. They diagnose problems, innovate to solve them, and spread the best ideas.
Let me give an example. Just a few years ago, the Indian state of Bihar was vaccinating under 30 percent. Then, a new chief minister, Nitish Kumar, was elected, and he made it clear that he expected change.
So even though Bihar is still one of the most challenging places in the world, but it’s no longer one of the least vaccinated. Under Chief Minister Kumar, the vaccination rate has more than doubled, and it plans to go higher.
I visited with Chief Minister Kumar two months ago, and his understanding of what was working and what wasn’t was impressive. He understood the innovations that were being tested.
Examples like this inspire all of us for better leadership. I was also struck by the chief minister’s popularity. People are hungry for visionary leaders who not only promise a better future, but take a basic system and make it work.
Today, I ask for your leadership. In 2005, you set two critically important immunization-related goals that we have not yet reached.
Let us renew our pledge that no country will be below 90 percent coverage. Let us rededicate ourselves to the idea that no district will be below 80 percent coverage. We will meet those goals if, and only if, you lead. With your leadership, you will make this the Decade of Vaccines.
As a global health community, it is imperative that we shine a light on the countries doing the best work. We need to know who the innovators are, so that the most powerful ideas spread far and wide.
Starting in 2012, the Gates Foundation will bestow an award on the individual or organization that has made the most uniquely innovative contribution to the Decade of Vaccines. This could be innovation in the science, delivery, or funding of vaccines. I will announce the winner every January in my annual letter. My goal is to make sure that pioneering global health leaders get the credit they deserve.
Polio
The long fight against polio proves just how powerful vaccine technology can be, but it also demonstrates that it is only as effective as the quality of delivery.
Twenty-three years ago, here in this building, the delegates to this Assembly resolved to wipe polio off the planet. And now we’re 99 percent of the way there, because of two things: a 13 cent vaccine so easy to administer that even I have done it many times; and the most impressive, farthest-reaching delivery effort global health has ever seen.
It is fantastic that more than 100 countries no longer have polio. In the most difficult conditions in the world, we are making stunning progress. Despite the ongoing war, Afghanistan has had only one case this year.
But progress is not the same as success, and eradication is not guaranteed. We have tools: diagnostics, surveillance systems, and vaccines that are constantly being improved, but the virus keeps spreading back into countries where it had been eliminated. There are countries where the virus continues to circulate, despite multiple campaigns every year. Globally, the polio programme is not assured of funding to keep running campaigns and improving vaccination systems.
These discouraging facts raise a question: do we really have the political commitment to eradicate polio?
Are donor countries, especially the G8, ready to close today’s funding gap and see the job through to the very end?
Are the countries where polio still exists ready to take extraordinary action to reach every single child with the vaccine?
We have a choice. We can keep doing what we’ve been doing, immunizing the same children over and over and missing the children who are the most vulnerable. Or we can do more. We can step up our fundraising, we can intensify our campaigns, and we can do what it takes to get to zero cases. If we make that choice, we will prove that people are capable of coming together to solve complex, worldwide problems.
The eradication of polio will be a great victory for this Assembly. You started the courageous fight against this disease. You will finish it. And then you will be able to move on to the next ambitious goal.
One of the polio leaders I respect most is Dr. Muhammad Pate, who directs Nigeria’s national eradication effort. Just a few years ago, Nigeria was the most troublesome spot on the polio map. It had hundreds of cases. Much worse, it lacked the commitment to bringing that number down.
But Dr. Pate, along with the global polio partners, President Goodluck Jonathan, and members of the ministry of health, helped rally government and traditional leaders around the cause. Dr. Pate told me that his agency makes a point of identifying poor-performing states publicly. That’s the kind of accountability that leads to results. Last year, thanks to a nationwide effort, polio was down 95 percent in Nigeria. Nigeria’s leaders still have a lot of work ahead of them, but they have turned the polio programme around.
During my last visit to Nigeria, Dr. Pate asked me a small favor. He hoped I’d be willing to sign his daughter’s school yearbook. I was more than willing, of course, and I want Dr. Pate’s daughter to know this: I admire her father very much, I want to someday introduce my children to him one day soon, and I hope more than anything that when that day comes we shall be celebrating the fact that there is no more polio in Nigeria.
Call to action
The world has a great opportunity right now, and whether or not we seize it will depend in large part on those of us in this room. It will depend on our ability to do the difficult, necessary things to usher in the Decade of Vaccines.
Donor countries, will have to increase investment in vaccines and immunization, even though they are coping with budget crises. The GAVI Pledging meeting in June gives you and your governments the opportunity to show your support. If donors are generous, we will prevent 4 million deaths by 2015. By 2020, we can prevent 10 million deaths.
Pharmaceutical companies, you must make sure vaccines are affordable for poor countries. Specifically, you must make a commitment to tiered pricing.
For all 193 Member States, you must make vaccines a high priority focus of your health systems, to ensure that all your children have access to existing vaccines now, and to new ones that have recently become available.
At the Gates Foundation, we are committed to working with all our partners – civil society, donors, drug companies, and national governments – to help you do the difficult but necessary things.
I am confident because I’ve seen so many examples of leadership.
British Prime Minister David Cameron passed the toughest austerity budget in his country’s memory. Yet, in the face of enormous pressure, he kept his promise to maintain development spending. A few months later, he announced that the United Kingdom would double its commitment to the polio campaign.
Another example is the Serum Institute of India, led by Dr. Cyrus Poonawalla, has broken the mold for the low-cost manufacture of vaccines. They developed the meningitis vaccine, they are the world’s largest producer of the measles vaccines, and they provide the pentavalent vaccine to GAVI at a lower price than any other manufacturer in the world. In the coming years they will manufacture inexpensive diarrhea and pneumonia vaccines.
Nitish Kumar and Muhammad Pate and many others have demonstrated that the best leaders can overcome tough challenges.
Together, and with your leadership, we can make this the decade in which we take full advantage of the technology of vaccines. When we do it, we will build an entirely new future based on the understanding that global health is the cornerstone of global prosperity.
It might be the most difficult thing we’ve ever done, but it will also be the most important.
Global health experts said on Thursday that the world’s most powerful drugs are losing the battle against drug-resistant strains of malaria, HIV, gonorrhea and tuberculosis
According to Dr. Thomas Frieden, director of the Centers for Disease Control and Prevention, antimicrobial resistance is robbing us of the certainty that antibiotics will always be there to fight infections and new drug-resistant pathogens are emerging. “It’s not enough to hope that we’ll have effective drugs to combat these infections. We must all act now to safeguard this important resource,” Frieden said
What you need to know about Anti-Microbial Resistance
What is Anti-Microbial Resistance:
Antimicrobial resistance occurs when germs change in a way that reduces or eliminates the effectiveness of drugs to treat them. This happens when antibiotics, antivirals, antifungals and other medications are used too liberally. About half of antimicrobial drugs — antibiotics in particular — are used unnecessarily or inappropriately prescribed in U.S. hospitals and in doctors’ offices, the CDC says. The best approach to preserving those drugs is to use them only when needed.
How Anti-Microbial Resistance affects developing world, especially Africa
HIV: Studies show that up to 20 percent of newly diagnosed HIV patients have transmitted a drug-resistant infection. Approximately 22 million people live with HIV in Sub-Saharan Africa. In the US and other developed countries, Doctors can test or resistance before prescribing drugs, but such luxury may be too hard to come by in under-privileged communities
Malaria: Plasmodium falciparum, the most dangerous of the malaria parasites, has developed resistance in nearly all areas of the world where it is transmitted. Annually, there are about 225 million malaria infections and nearly 800,000 deaths. Women and children are the most affected, particularly in Sub-Saharan Africa.
Celebrity Singer Kelly Clarkson boosted the spirits of a group of underprivileged children by visiting an orphanage during a charity trip to Cape Town, South Africa.
The singer met the residents of the House of Hope, an organization which looks after abused and forsaken children most of whom are infected with HIV.
The hit actress discussed her experience in a post on Facebook.com, writing, “I just got back from Africa and had so much fun! I got to hang with the House Of Hope kids and go on a mini safari with some friends and family. I love South Africa! I love those kids even more.
“If you don’t know, House of Hope is an orphanage in South Africa that I got involved with a little over a year ago. They house around 30 kids right now and have had a rough life but you wouldn’t know it because they are the greatest kids with the best hearts, laughs, and smiles!”
HIV stereotypes remain the biggest barrier in containing the spread of the disease and celebrity interaction with HIV patients play a big role in combating the stigma
Volunteers who participated in a study on reducing the risk of HIV infection in women listened as the test results were announced during a meeting in Vulindlela, Kwazulu-Natal, South Africa. Photo by (Joao Silva for The New York Times)
K. Amponsah-Manager
Among the estimated 22.5 million people living with HIV in Sub-Saharan Africa, women and girls continue to be disproportionately represented. In South Africa, for instance, it is estimated that one-in-three women aged 25-29 are living with HIV (Human Sciences Research Council (2009). Another estimate puts the proportion of maternal orphans – those who have lost their mother – orphaned by AIDS as over 70 percent (Budlender, D. et al., 2008). This is surely a dispiriting statistic. Several reasons can be attributed to this trend including rape and other sexual abuses, cultural practices and societal expectations of women. There are also biological factors that contribute to this inclination. For instance, the female genitals have a more exposed surface area than the male genitals have. Also, there are higher amounts of HIV in semen than in vaginal fluids while again more semen is exchanged during sex than vaginal fluids. These together with the social and cultural factors above precipitate a situation that places the woman at a more disadvantage point of view.
There are several steps communities and policy makers can take to reduce the women’s vulnerability to the epidemic and reverse this distressful trend. These include:
Involving men: In a typical African relationship, the man controls when and how sex happens. The man decides the frequency of sex and whether any protection is used during sexual relationship. The current education targeting men to use condoms should continue but it should place a bigger accent on educating men to respect the women’s choice and needs in sexual relationships. Gender-based violence and stereotypes should be core of any anti-HIV campaigns in African communities.
Accessibility to healthcare needs: Past anti-HIV and family planning campaigns have focused on the man, but it is time to pay attention to the needs of the woman if we can really cut the percentage of women that continue to be afflicted by the HIV epidemic. While the female condom (FC) is available to most women in the developed countries who want to use it, FC is merely another indulgence that the African woman cannot just afford. The situation gets even more challenging as the female condom can be several times more expensive than the male condom. It is therefore crucial for health policy makers and private organization to step in and offer to make these products accessible to the women at a cost that they can afford. Also, women who are abused sexually should have free access to blood tests and other medical services to determine their status. This will halt the further spread of HIV and other sexually-transmitted diseases (STDs) they might have contracted during the assault. Studies show that women with other untreated STDs are more likely to contract the HIV virus than their STD-free counterparts or those who have access the reproductive healthcare needs.
Economic Opportunities and Education: It is sad fact that in the African society, the bread-winner is automatically self-empowered to call the shots and since in most cases, it is the man who holds that title, the women in these societies are the always at the receiving end when it comes to decisions affecting sexual intercourse. A journey to economic empowerment will be relatively long, but in the long run, it is the surest strategy that will place women in positions that they can influence decisions that affect their own lives. According to the UNAIDS, women without education are four times more likely to have the belief that there is no way to prevent HIV. These women do not expect and do not demand any protection during sex even when they know their partners have multiple sexual partners. Early sexual intercourse and early marriages are big factors in predicting a girl’s vulnerability to HIV. In Niger, for example, 50% of girls get married by the age of 15. However, studies show that girls with more education tend to delay marriage and tend to delay their first sexual intercourse. Providing every girl child with at least the basic education will certainly make a dent.
Campaign against social and cultural practices harmful to the woman: Some practices are ‘universally’ classified as sexual violence but are accepted practices in some communities across African and other parts of the world. These include female genital mutilation or female circumcision, marital rape and girl trafficking. In a survey in Kenya, 14% of women said their own husbands (most of whom have multiple sexual partners) had raped them in the past. All these practices disproportionately expose women and girls to HIV and other sexually transmitted diseases. According to the UN, women who have experienced any of such abuses are three times more likely to be infected by HIV.
Reducing the woman’s vulnerability to HIV is vital in curbing the prevalence and saving the unborn. In fact 390 000 out of the global 430 000 children newly infected with HIV during 2008 were from sub-Saharan Africaas a result of mother-to-child transmission (USAIDS). Why should we wait any longer in tackling the woman’s sexual health needs?